Request Free Sample
×
Onychomycosis Drug Market
ID: MRFR/Pharma/36969-HCR
100 Pages
October 2025
Rapport d’étude de marché sur les médicaments contre l’onychomycose par type de médicament (antifongique topique, antifongique oral, thérapie combinée), par forme posologique (comprimé, crème, solution, spray), par voie d’administration (topique, orale), par données démographiques des patients (adultes, gériatrie, pédiatrie) et par région (Amérique du Nord, Europe, Amérique du Sud, Asie-Pacifique, Moyen-Orient et Afrique) – Prévisions jusqu’en 2034
Les principales entreprises du marché Onychomycosis Drug Market incluent
Portée du rapport
Laisser un commentaire
FAQs
What is the current valuation of the Onychomycosis Drug Market as of 2024?
The Onychomycosis Drug Market was valued at 4.659 USD Billion in 2024.
What is the projected market valuation for the Onychomycosis Drug Market in 2035?
The market is projected to reach 9.84 USD Billion by 2035.
What is the expected CAGR for the Onychomycosis Drug Market during the forecast period 2025 - 2035?
The expected CAGR for the Onychomycosis Drug Market during 2025 - 2035 is 7.03%.
Which companies are considered key players in the Onychomycosis Drug Market?
Key players in the market include Novartis, Bayer, Janssen Pharmaceuticals, Merck & Co., GlaxoSmithKline, Pfizer, AbbVie, Astellas Pharma, and Sanofi.
What are the market segments for Onychomycosis drugs based on type?
The market segments based on type include Topical Antifungal, Oral Antifungal, and Combination Therapy, with valuations of 3.2, 4.5, and 2.14 USD Billion respectively by 2035.
How does the Onychomycosis Drug Market segment by dosage form?
The market segments by dosage form include Tablet, Cream, Solution, and Spray, with projected valuations of 3.2, 2.5, 2.1, and 2.0 USD Billion respectively by 2035.
What are the projected valuations for the Onychomycosis Drug Market by route of administration?
By 2035, the projected valuations for the Onychomycosis Drug Market by route of administration are 5.88 USD Billion for Topical and 3.96 USD Billion for Oral.
How is the Onychomycosis Drug Market segmented by patient demographics?
The market is segmented by patient demographics into Adults, Geriatrics, and Pediatrics, with projected valuations of 5.5, 3.5, and 0.84 USD Billion respectively by 2035.
What is the growth outlook for the Onychomycosis Drug Market in the coming years?
The Onychomycosis Drug Market is expected to experience robust growth, reaching nearly 9.84 USD Billion by 2035.
What factors may influence the growth of the Onychomycosis Drug Market?
Factors influencing growth may include advancements in drug formulations, increasing awareness of onychomycosis, and the expanding geriatric population.
Télécharger l'échantillon gratuit
Veuillez remplir le formulaire ci-dessous pour recevoir un échantillon gratuit de ce rapport
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
Noah Malgeri
Co-Founder
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
Joseph Aguayo
Sales Operations & Pricing Manager
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
Peter Groot koerkamp
Account and Business Manager
“Thank you, this will be very helpful for OQS.”
La Terria Dodd
Program Support Specialist
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
Younghwan Choi
Senior Retail Manager
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
Mark Irwin
Management Consultant
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
Akif Moroglu
Strategy & Business Development Director
Étude de cas
Aerospace & Defense